AKT1 and cancer: A recent study reported that the inhibition of PI3K–AKT-mTOR signaling sensitizes cancer cells to ferroptosis induction via ablation of SREBP1/SCD1-mediated production of MUFA, which inhibits ferroptosis [21, 40].